These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30626765)

  • 21. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L; Kilkenny E; Ferasin H
    J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
    D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
    Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Fan P; Zhang Y; Lu YT; Yang KQ; Lu PP; Zhang QY; Luo F; Lin YH; Zhou XL; Tian T
    Heart; 2021 May; 107(10):836-841. PubMed ID: 33055147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Costabel JP; Galve E; Terricabras M; Ametrano C; Ronderos R; Baranchuk A; Evangelista A; Avegliano G
    Echocardiography; 2018 Jul; 35(7):935-940. PubMed ID: 29505666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The left atrial phasic functions and the relationship with plasma N-terminal pro-B-type natriuretic peptide levels and symptomatic states in patients with hypertrophic cardiomyopathy.
    Tülüce K; Yakar Tülüce S; Yavuzgil O; İsayev E; Bilgin M; Akyıldız Akçay F; Nalbantgil S; Özerkan F
    Anadolu Kardiyol Derg; 2014 Dec; 14(8):719-27. PubMed ID: 25188761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
    Doesch C; Lossnitzer D; Rudic B; Tueluemen E; Budjan J; Haubenreisser H; Henzler T; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Med Sci; 2016; 13(1):1-7. PubMed ID: 26812947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
    Faludi R; Tóth L; Pótó L; Cziráki A; Simor T; Papp L
    Orv Hetil; 2005 Jan; 146(1):23-6. PubMed ID: 15715369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kwapiszewska A; Kukula K; Jamiolkowski J; Dabrowski M; Derejko P; Oreziak A; Baranowski R; Spiewak M; Marczak M; Klisiewicz A; Szepietowska B; Chmielak Z; Witkowski A
    Clin Cardiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30120784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy.
    Matsuura H; Murakami T; Hina K; Yamamoto K; Kawamura H; Sogo T; Shinohata R; Usui S; Ninomiya Y; Kusachi S
    Clin Biochem; 2008 Feb; 41(3):134-9. PubMed ID: 18039472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma big endothelin-1 predicts new-onset atrial fibrillation after surgical septal myectomy in patients with hypertrophic cardiomyopathy.
    Song C; Wang S; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
    BMC Cardiovasc Disord; 2019 May; 19(1):122. PubMed ID: 31117937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.
    Wang Y; Tang Y; Zou Y; Wang D; Zhu L; Tian T; Wang J; Bao J; Hui R; Kang L; Song L; Wang J
    Int J Cardiol; 2017 Sep; 243():283-289. PubMed ID: 28587741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic dilated cardiomyopathy and chronic atrial fibrillation.
    Tuomainen PO; Magga J; Fedacko J; Kärkkäinen S; Miettinen K; Vanninen E; Kuusisto J; Peuhkurinen KJ
    Clin Physiol Funct Imaging; 2014 Mar; 34(2):133-7. PubMed ID: 23879372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.
    Horjen AW; Ulimoen SR; Norseth J; Svendsen JH; Smith P; Arnesen H; Seljeflot I; Tveit A
    Scand J Clin Lab Invest; 2018 Sep; 78(5):386-392. PubMed ID: 29933716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: comparisons of sympathetic activity and left atrial size.
    Akutsu Y; Kaneko K; Kodama Y; Miyoshi F; Li HL; Watanabe N; Asano T; Tanno K; Suyama J; Namiki A; Gokan T; Kobayashi Y
    J Interv Card Electrophysiol; 2013 Nov; 38(2):79-84. PubMed ID: 24026966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
    Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
    Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
    Saura D; Marín F; Climent V; González J; Roldán V; Hernández-Romero D; Oliva MJ; Sabater M; de la Morena G; Lip GY; Valdés M
    Int J Clin Pract; 2009 Oct; 63(10):1465-71. PubMed ID: 19769703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.